ArticleOrphanet journal of rare diseases2026
A mixed methods study of the impact of WAGR spectrum disorder on individuals and their caregivers.
Article in Orphanet journal of rare diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundWAGR spectrum disorder (WSD) is a rare genetic condition classically characterized by Wilms tumor, Aniridia, Genitourinary abnormalities, and Range of developmental delay. Following our publication, the terminology has shifted from “syndrome” to “spectrum disorder” to better capture its phenotypic variability.1 While other multi-systemic features have been identified, there is a paucity of literature around how WSD impacts individuals and their families. To guide clinical management recommendations and development of outcome measures for WSD clinical studies, this study explored the lived experiences of children with WSD and their caregivers.
methodsFourteen caregivers to 13 children with WSD participated in this two-part study, consisting of a survey that collected medical information for each child with WSD and semi-structured interviews that focused on how WSD impacts daily life. Survey data were analyzed using descriptive statistics. Interview data were analyzed using reflexive thematic analysis within a critical realism framework.
resultsAniridia was the most frequently reported health condition, although a broad range of co-occurring conditions exemplified clinical heterogeneity of WSD. Analysis of caregiver interviews generated five key themes: (1) uncertainty has a profound emotional impact on caregivers, (2) while the prospect of lifelong caregiving is stressful, caring for a child with WSD is rewarding, (3) partnerships between healthcare providers and families are critical, (4) three areas to prioritize for assessment in future WSD clinical studies include aniridia/vision, behavioral/psychiatric, and speech/communication conditions, and (5) the WSD community is a powerful support system.
conclusionsThis study offers valuable insight into the multifaceted impacts of WSD on individuals and their caregivers. Our findings highlight key therapeutic targets and opportunities to improve clinical care and support for the WSD community.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.